DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Jubilant Ingrevia Limited — Updates

NSE 1 hr ago·13 Oct 2026, 9:43 am

Jubilant Ingrevia

Jubilant Ingrevia Limited has released an update regarding its business operations and strategic outlook. The company has provided information intended to clarify its current standing and future plans for its manufacturing and distribution segments.

This announcement is significant for investors as it offers transparency into the company's trajectory. It helps the market better understand the management's vision and how the business intends to navigate the competitive landscape in the specialty chemicals and pharmaceutical ingredients sectors.

Investors should monitor the specific details of the update to gauge its impact on the company's financial performance and operational efficiency. Keeping an eye on future quarterly results will be essential to fully assess the implications of this news.